Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JMP Securities Downgrades Intellia Therapeutics to Market Perform

JMP Securities Downgrades Intellia Therapeutics to Market Perform

JMP Securities analyst Silvan Tuerkcan downgrades Intellia Therapeutics (NASDAQ:NTLA) from Market Outperform to Market Perform.

byBenzinga Newsdesk

January 19, 2023

1 minute read

JMP Securities analyst Silvan Tuerkcan downgrades Intellia Therapeutics (NASDAQ:NTLA) from Market Outperform to Market Perform.

What’s Going On With Nvidia Stock Thursday?

By Anusuya Lahiri

September 21, 8:34 AM

Nvidia Corp (NASDAQ: NVDA) stock is trading lower Thursday as the company continue

AAPL

Berkshire Hathaway Withdraws From India’s Paytm, Concluding Multi-Million Dollar Share Disposal: Report

By Nabaparna Bhattacharya

November 24, 1:38 PM

Berkshire Hathaway Inc. (NYSE: BRK-A) (NYSE: BRK-B) has reportedly divested its 2.5% holding in India's Paytm, selling the stake in the digital

SFBQF

Aurora Cannabis Takes Bold Step Towards Financial Recovery

By Jelena Martinovic

September 11, 8:20 AM

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has repurchased an aggregate of roughly CA$12.3 million ($9 million) principal amount of its convertible senior notes in multiple transactions between August 16 and September 8, 2023.

ACB

Analyst Ratings

Analyst Ratings for Huntsman

By Benzinga Insights

November 8, 2:21 PM

Huntsman (NYSE:HUN) has observed the following analyst ratings within the last quarter:

HUN

JMP Securities Downgrades Intellia Therapeutics to Market Perform

Related Posts

What’s Going On With Nvidia Stock Thursday?

Berkshire Hathaway Withdraws From India’s Paytm, Concluding Multi-Million Dollar Share Disposal: Report

Aurora Cannabis Takes Bold Step Towards Financial Recovery

Analyst Ratings for Huntsman